A Study to Assess the Efficacy and Safety of ABTL0812
Status:
Completed
Trial end date:
2020-11-15
Target enrollment:
Participant gender:
Summary
A phase I/ II, open label study to assess the efficacy and safety of ABTL0812 in combination
with paclitaxel and carboplatin in patients with advanced endometrial cancer or squamous
NSCLC.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ability Pharmaceuticals SL
Collaborators:
Centre Leon Berard Gustave Roussy, Cancer Campus, Grand Paris Hospital Clínico Universitario de Valencia Hospital Vall d'Hebron Hospitales Universitarios Virgen del Rocío Institut Català d'Oncologia Institut Paoli-Calmettes